VANCOUVER, BC, Aug. 8, 2024
/PRNewswire/ -- EmeTerm® Smart uses patented hybrid technology to
seamlessly integrate the functionality of a smartwatch with that of
an anti-nausea wristband, ensuring a carefree and healthy life for
all. EmeTerm® Smart is launching on Indiegogo as the world's first
anti-nausea smart watch.
EmeTerm® Smart's story is one of heartfelt innovation. In 2010,
the founder's wife experienced severe morning sickness during her
pregnancy. Frustrated by the lack of effective, drug-free
solutions, he was inspired to create a device that could help not
only his wife but also countless others suffering from nausea.
Driven by love and determination, he assembled a team of passionate
and experienced professionals who shared his vision and founded WAT
Medical, a Canadian medical technology company, in 2015.
Since its establishment, WAT Medical has dedicated years to
developing high-precision, wearable medical devices to prevent
debilitating conditions like nausea, migraines, and obesity.
Co-founder, Peter Ji, who holds a
Doctorate in Optometry from the University of
California, Berkeley, states that the entire team firmly
believes in the integration of advanced technology and
patient-centered care to make a positive impact on the global
medical landscape. In alignment with this vision, WAT Medical
actively fulfills its social responsibilities by contributing to
esteemed organizations such as M.D. Anderson Cancer Center, the
Canadian Red Cross, and Peace Arch Hospital. Furthermore, WAT
Medical supports vulnerable groups, including veterans and patients
with rare conditions such as EDS and HDS, through various
charitable initiatives.
Today, WAT Medical is proud to introduce a new smart device that
exceeds expectations and transforms lives. The EmeTerm® Smart
anti-nausea wristband utilizes transcutaneous electrical nerve
stimulation (TENS) to provide a drug-free, side-effect-free
solution for all types of nausea and vomiting. FDA-approved and
boasting a success rate of up to 85%, EmeTerm® Smart effectively
combats nausea in a safe and natural manner.[1]
Additionally, a study published in the British Journal of
Anesthesia (BJA) confirms that wearable TENS wristbands can
effectively prevent postoperative nausea and vomiting. On
February 27, 2023, Ohio State University further validated its
efficacy through testing and analysis of both subjective patient
responses and objective physiological data.
The new EmeTerm® Smart model also stands out with its smart
features. Users can adjust the electrical stimulation level via a
touch-sensitive screen with a clear interface. Moreover, it offers
timekeeping and step counting to help users better understand and
improve their health. With an IP67 waterproof rating, EmeTerm®
Smart can stay submerged in 1-meter-deep water for 30 minutes and
is completely protected from dust, ensuring it can be used in
various situations.
EmeTerm® Smart will be released via Indiegogo in August 2024. The MSRP is $299, with early backers enjoying up to 39% off.
Visit the EmeTerm® Smart's Indiegogo page to learn more: Indiegogo
page.
[1]
Wang N, Ding P, Zheng D Y, et al. Wearable transcutaneous
electrical acupoint stimulation bracelet for prevention of
postoperative nausea and vomiting in patients undergoing
hysteroscopic surgery: a randomised controlled trial[J]. British
Journal of Anaesthesia, 2022, 129(4): e85-e87.
https://www.bjanaesthesia.org.uk/article/S0007-0912(22)00348-8/fulltext
|
Media Contact:
Company Name: WAT Medical
Contact: EmeTerm
Email: info@emeterm.com
Website: EmeTerm
View original content to download
multimedia:https://www.prnewswire.com/news-releases/innovative-anti-nausea-smartwatch-emeterm-smart-set-to-launch-on-indiegogo-302214305.html
SOURCE WAT Medical Enterprise Ltd.